1. Orphan drug policies and use in pediatric nephrology

   • Diana Karpman
   • Peter Höglund

   Editorial Commentary 13 October 2016 Pages: 1 - 6

2. A holey pursuit: lumen formation in the developing kidney

   • Denise K. Marciano

   Review 22 February 2016 Pages: 7 - 20

   

3. The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy

   • Guido Filler
   • Ana Catalina Alvarez-Elías
   • Mara Medeiros

   Review 26 February 2016 Pages: 21 - 29

   

4. The spectrum of autosomal dominant polycystic kidney disease in children and adolescents

   • Bharathi V. Reddy
   • Arlene B. Chapman

   Review 31 March 2016 Pages: 31 - 42

   

5. C3 Glomerulopathy

   • Magdalena Riedl
   • Paul Thorner
   • Christoph Licht

   Educational Review 07 April 2016 Pages: 43 - 57

   

6. Drug-associated acute kidney injury: who’s at risk?

   • Emily L. Joyce
   • Sandra L. Kane-Gill
   • John A. Kellum

   Educational Review 23 June 2016 Pages: 59 - 69

   

7. A neonate with poor weight gain and hyperkalemia: Questions

   • Chiung-Chen Liu
   • Shih-Hua Lin
   • Chien-Ming Lin

   Clinical Quiz 01 December 2015 Pages: 71 - 71

8. A neonate with poor weight gain and hyperkalemia: Answers

   • Chiung-Chen Liu
   • Shih-Hua Lin
   • Chien-Ming Lin

   Clinical Quiz 01 December 2015 Pages: 73 - 75

   

9. An unusual case of renal failure: Questions

   • Alison Ma
   • Rukshana Shroff
   • Stephen D. Marks

   Clinical Quiz 11 January 2016 Pages: 77 - 78

   

10. An unusual case of renal failure: Answers

    • Alison Ma
    • Rukshana Shroff
    • Stephen D. Marks

    Clinical Quiz 11 January 2016 Pages: 79 - 80

11. Genotype–phenotype analysis of pediatric patients with WT1 glomerulopathy

    • Yo Han Ahn
    • Eu Jin Park
    • Hae Il Cheong

    Original Article 14 June 2016 Pages: 81 - 89

    

12. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study

    • Thurid Ahlenstiel-Grunow
    • Nele K. Kanzelmeyer
    • Lars Pape

    Original Article 27 June 2016 Pages: 91 - 97

    

13. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children

    • Karnika Raja
    • Ami Parikh
    • Daljit Hothi

    Original Article 27 September 2016 Pages: 99 - 105

    

14. Flushing of the vagina and the prepuce—a cause for contaminated urine cultures in children

    • Kjell Tullus
    • Nakysa Hooman
    • Marina Easty

    Original Article 01 August 2016 Pages: 107 - 111

    

15. Normal values of urine total protein- and albumin-to-creatinine ratios in term newborns

    • Chahrazed El Hamel
    • Thierry Chianea
    • Vincent Guigonis

    Original Article 15 June 2016 Pages: 113 - 118

    

16. Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents

    • Siah Kim
    • Petra Macaskill
    • Jonathan C. Craig

    Original Article 23 June 2016 Pages: 119 - 129

    

17. Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations

    • Johanna Stock
    • Johannes Kuenanz
    • Oliver Gross

    Original Article 11 July 2016 Pages: 131 - 137

    

18. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

    • Rosanna Coppo
    • Danilo Lofaro
    • Eva Honsova

    Original Article 25 August 2016 Pages: 139 - 150

    

19. Preterm neonatal urinary renal developmental and acute kidney injury metabolomic profiling: an exploratory study

    • Kelly Mercier
    • Susan McRitchie
    • Susan Sumner

    Original Article 19 July 2016 Pages: 151 - 161

    

20. Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides

    • Lorraine Lau
    • Zubaida Al-Ismaili
    • Michael Zappitelli

    Original Article 14 October 2016 Pages: 163 - 171

    

21. Previous aminoglycoside use and acute kidney injury risk in non-critically ill children

    • Jeremy Andrew Saban
    • Michael Pizzi
    • Michael Zappitelli

    Original Article 07 October 2016 Pages: 173 - 179

22. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab

    • Marina Vivarelli
    • Manuela Colucci
    • Gianmarco Ghiggeri

    Brief Report 29 September 2016 Pages: 181 - 184

23. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient

    • Isabella Guzzo
    • Federica Morolli
    • Luca Dello Strologo

    Brief Report 17 October 2016 Pages: 185 - 188

    

24. Ten-year treatment with mycophenolate mofetil using therapeutic drug monitoring for childhood-onset lupus nephritis in Japan

    • Shuichiro Fujinaga
    • Tomohiko Nishino

    Letter to the Editors 13 October 2016 Pages: 189 - 190

25. Response to comments from Fujinaga and Nishino regarding the article “Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis”

    • Pornpimol Rianthavorn

    Letter to the Editor 13 October 2016 Pages: 191 - 192

26. Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

    • Rosanna Coppo
    • Danilo Lofaro
    • Eva Honsova

    Erratum 04 October 2016 Pages: 193 - 194